Arm, Marvell among market cap stock movers on Friday
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Indaptus Therapeutics Inc (INDP)
Indaptus Therapeutics Inc stock price live, this page displays NASDAQ INDP stock exchange data. View the INDP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Indaptus Therapeutics Inc real time stock price chart below.
What Is the Indaptus Therapeutics Inc Stock Price Today?
The Indaptus Therapeutics Inc stock price today is 3.570.
What Is the Stock Symbol for Indaptus Therapeutics Inc?
The stock symbol for Indaptus Therapeutics Inc is "INDP."
What Stock Exchange Does Indaptus Therapeutics Inc Trade On?
Indaptus Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Indaptus Therapeutics Inc a Good Stock to Buy?
Determining whether Indaptus Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INDP quote. (ISIN: US45339J2042)
What Is the Indaptus Therapeutics Inc Stock Price Today?
The Indaptus Therapeutics Inc stock price today is 3.570.
What Is the Stock Symbol for Indaptus Therapeutics Inc?
The stock symbol for Indaptus Therapeutics Inc is "INDP."
What Stock Exchange Does Indaptus Therapeutics Inc Trade On?
Indaptus Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Indaptus Therapeutics Inc a Good Stock to Buy?
Determining whether Indaptus Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INDP quote. (ISIN: US45339J2042)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.430
3.800
52 wk Range
0.920
19.914
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.4303.800
52 wk Range
0.92019.914
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INDP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
10.000
Upside
+180.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Mega-cap and large-cap stock movers on Friday
- Investing.com
- Form 13G Indaptus Therapeutics For: 6 April
- Investing.com
- Form 10Q Indaptus Therapeutics Inc For: 15 May
- Investing.com
- Arm, Marvell among market cap stock movers on Friday
- Investing.com
- Mega-cap and large-cap stock movers on Friday
- Investing.com
- Form 10Q Indaptus Therapeutics Inc For: 15 May
- Investing.com
- Form 13D/A Indaptus Therapeutics For: 29 April
- Investing.com
- Form 8K Indaptus Therapeutics Inc For: 24 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 10.000
(+180.11% Upside)
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-0.23 / --
Revenue / Forecast
-- / --
Compare INDP to Peers and Sector
Metrics to compare | INDP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINDPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.4x | −8.4x | −0.5x | |
PEG Ratio | −0.17 | 0.02 | 0.00 | |
Price/Book | 324.0x | 3.8x | 2.6x | |
Price / LTM Sales | - | 33.0x | 3.0x | |
Upside (Analyst Target) | 180.1% | 53.6% | 58.6% | |
Fair Value Upside | Unlock | −3.7% | 10.2% | Unlock |
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Indaptus (INDP) Stock Price Today?
The Indaptus stock price today is 3.570 USD.
What Stock Exchange Does Indaptus Trade On?
Indaptus is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Indaptus?
The stock symbol for Indaptus is "INDP."
What Is the Indaptus Market Cap?
As of today, Indaptus market cap is 404.280M USD.
What Is Indaptus's Earnings Per Share (TTM)?
The Indaptus EPS (TTM) is -5.266.
When Is the Next Indaptus Earnings Date?
Indaptus will release its next earnings report on Aug 18, 2025.
From a Technical Analysis Perspective, Is INDP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Indaptus Stock Split?
Indaptus has split 3 times.
How Many Employees Does Indaptus Have?
Indaptus has 5 employees.
What is the current trading status of Indaptus (INDP)?
As of Jun 12, 2026, Indaptus (INDP) is trading at a price of 3.570 USD, with a previous close of 3.570 USD. The stock has fluctuated within a day range of 2.430 USD to 3.800 USD, while its 52-week range spans from 0.920 USD to 19.914 USD.
What Is Indaptus (INDP) Price Target According to Analysts?
The average 12-month price target for Indaptus is 10.000 USD, with a high estimate of 10 USD and a low estimate of 10 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +180.11% Upside potential.
What Is the INDP Premarket Price?
INDP's last pre-market stock price is 3.520 USD. The pre-market share volume is 25,990.000, and the stock has decreased by -0.050, or -1.400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.